Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
HRS Aluglaze Shares Surge After Strong FY26 Results Revenue Jumps 60 Trumps Iran Deal Dissatisfaction What It Means for Geopolitical Risk and Oil Markets South Koreas Kospi Surges to Record High Amid Renewed USIran Peace Hopes Boston Beer Company SAM Faces Price Target Cut by Morgan Stanley Amid Cost and Macro Headwinds Nearly 1 Billion Flows Into LQD ETF InvestmentGrade Bonds Attract Significant Capital Amcor plc AMCR Q1 2026 Earnings EPS Misses Estimates Amid Cost Headwinds PennantPark Floating Rate Capital Ltd PFLT Q1 2026 Earnings EPS Misses Estimates Amid FloatingRate Portfolio Adjustments CRGO Q4 2025 Earnings Narrower Loss Slightly Ahead of Expectations NuCana Q3 2024 Earnings SmallerthanExpected Loss as Biotech Advances Oncology Pipeline PrimeEnergy Resources PNRG Q4 2025 Earnings Profitability Holds Firm with EPS of 143 Stock Advances 454 WhiteHorse Finance Inc WHF Gains 272 as Stock Tests Key Resistance Near 714 Cantor Equity Partners III Inc CAEP Holds Steady at 1500 as Consolidation Continues ePlus Inc PLUS Advances 21 Closing In on 93 Resistance Beneficient BENF Holds Steady Near Support as Modest Gains Emerge Paul Tudor Jones Says No Chance Kevin Warsh Cuts Fed Rates Heres Why Surging Treasury Yields Challenge RiskFree Label Opening Doors in Intermediate Bonds BBBs and High Yield Shells Capital Return Strategy Gains Renewed Investor Attention Analyst Report Highlights Potential for Pinterest Inc Amid Evolving Digital Advertising Landscape DLX Q1 2026 Earnings Strong EPS Beat Amidst Ongoing Strategic Transformation MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline AGIG Q3 2012 Earnings Massive EPS Miss as Company Reports Significant Loss UPBD Q1 2026 Earnings EPS Beats Estimates by 247 ZEPP Q3 2025 Earnings Narrowed Loss Amid Mixed Operational Signals TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment